Hamid Mirshahidi

820 total citations
43 papers, 609 citations indexed

About

Hamid Mirshahidi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hamid Mirshahidi has authored 43 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Hamid Mirshahidi's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Hamid Mirshahidi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Hamid Mirshahidi collaborates with scholars based in United States, Taiwan and France. Hamid Mirshahidi's co-authors include Chung-Tsen Hsueh, Yuan Yuan, Yu-Min Liao, David A. Bush, Jerry D. Slater, Roger Grove, Saied Mirshahidi, Gayathri Nagaraj, Kiumarss Nasseri and Jason Wallen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hamid Mirshahidi

37 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamid Mirshahidi United States 12 291 212 164 134 99 43 609
Jane‐Chloé Trone France 10 165 0.6× 142 0.7× 150 0.9× 107 0.8× 61 0.6× 43 501
Troels Bechmann Denmark 13 217 0.7× 89 0.4× 130 0.8× 113 0.8× 28 0.3× 30 458
Irving Taylor United Kingdom 10 281 1.0× 123 0.6× 100 0.6× 154 1.1× 66 0.7× 30 657
Dae Sik Yang South Korea 16 204 0.7× 190 0.9× 87 0.5× 110 0.8× 155 1.6× 85 806
Christina H. Son United States 11 291 1.0× 269 1.3× 167 1.0× 195 1.5× 66 0.7× 35 888
L Buffoni Italy 15 321 1.1× 498 2.3× 186 1.1× 94 0.7× 117 1.2× 49 812
Tabassum Wadasadawala India 15 265 0.9× 163 0.8× 56 0.3× 261 1.9× 139 1.4× 74 684
N.S. Russell Netherlands 8 226 0.8× 116 0.5× 54 0.3× 146 1.1× 63 0.6× 15 547
Afsheen N. Iqbal United States 9 341 1.2× 327 1.5× 82 0.5× 75 0.6× 20 0.2× 26 578
Roman Makarewicz Poland 12 92 0.3× 127 0.6× 122 0.7× 106 0.8× 38 0.4× 73 461

Countries citing papers authored by Hamid Mirshahidi

Since Specialization
Citations

This map shows the geographic impact of Hamid Mirshahidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Mirshahidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Mirshahidi more than expected).

Fields of papers citing papers by Hamid Mirshahidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Mirshahidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Mirshahidi. The network helps show where Hamid Mirshahidi may publish in the future.

Co-authorship network of co-authors of Hamid Mirshahidi

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Mirshahidi. A scholar is included among the top collaborators of Hamid Mirshahidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Mirshahidi. Hamid Mirshahidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, B. Kevin, Joshua Kim, David J. Baylink, et al.. (2025). Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment. Journal of Translational Medicine. 23(1). 633–633. 1 indexed citations
2.
Elliott, Andrew, Yasmine Baca, Mark E. Reeves, et al.. (2024). Unlocking therapeutic potential: IL-1β as a target in non-small cell lung cancer with oncogenic mutations—Prognostic and predictive insights.. Journal of Clinical Oncology. 42(16_suppl). 8030–8030. 1 indexed citations
3.
Park, Daniel, Kiwon Park, Mark E. Reeves, et al.. (2023). Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management. International Journal of Molecular Sciences. 24(14). 11547–11547. 8 indexed citations
4.
Mirshahidi, Hamid, et al.. (2023). Hemoglobin Response to Zinc Supplementation in Patients with Zinc Deficiency and Chronic Anemia. Blood. 142(Supplement 1). 5222–5222. 1 indexed citations
5.
Mirshahidi, Saied, et al.. (2023). NCOA-RET fusion as a secondary resistance mechanism to osimertinib in complex EGFR-mutated lung adenocarcinoma: Case report and review of literature. SHILAP Revista de lepidopterología. 10. 100232–100232. 1 indexed citations
6.
Mirshahidi, Hamid, et al.. (2023). Hemoglobin Response to Zinc Supplementation in Chronic Kidney Disease in Patients with Zinc Deficiency and Anemia. Blood. 142(Supplement 1). 3827–3827.
7.
Mirshahidi, Saied, Rosalia de Necochea-Campion, Mark E. Reeves, et al.. (2019). Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro. Cancer Investigation. 38(1). 23–36. 5 indexed citations
8.
Nahleh, Zeina, Hamid Mirshahidi, Gayathri Nagaraj, et al.. (2018). Disparities in breast cancer: a multi‐institutional comparative analysis focusing on American Hispanics. Cancer Medicine. 7(6). 2710–2717. 26 indexed citations
9.
Shaheen, Shagufta, Hamid Mirshahidi, Gayathri Nagaraj, & Chung-Tsen Hsueh. (2018). Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature. Experimental Hematology and Oncology. 7(1). 11–11. 33 indexed citations
10.
Necochea-Campion, Rosalia de, et al.. (2017). Metastatic biomarkers in synovial sarcoma. Biomarker Research. 5(1). 4–4. 29 indexed citations
11.
12.
13.
Raza, Anwar, Huynh Cao, Camilla J. Cobb, et al.. (2015). Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature. Expert Review of Anticancer Therapy. 15(10). 1199–1213. 12 indexed citations
14.
Bush, David A., Sharon S. Lum, Carlos A. Garberoglio, et al.. (2014). Partial Breast Radiation Therapy With Proton Beam: 5-Year Results With Cosmetic Outcomes. International Journal of Radiation Oncology*Biology*Physics. 90(3). 501–505. 64 indexed citations
15.
Khan, Nawazish A., Saied Mirshahidi, & Hamid Mirshahidi. (2014). A Novel Insertion Mutation on Exon 20 of Epidermal Growth Factor Receptor, Conferring Resistance to Erlotinib. Case Reports in Oncology. 7(2). 491–496. 5 indexed citations
16.
Hurvitz, Sara A., Florence Dalenc, Mario Campone, et al.. (2013). A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy. Breast Cancer Research and Treatment. 141(3). 437–446. 58 indexed citations
17.
Bush, David A., Gregory Cheek, Salman Zaheer, et al.. (2013). High-Dose Hypofractionated Proton Beam Radiation Therapy Is Safe and Effective for Central and Peripheral Early-Stage Non-Small Cell Lung Cancer: Results of a 12-Year Experience at Loma Linda University Medical Center. International Journal of Radiation Oncology*Biology*Physics. 86(5). 964–968. 80 indexed citations
18.
Mirshahidi, Hamid, et al.. (2012). Abstract 2663: Phase I study of azacitidine and cisplatin in patients with advanced head and neck or non-small cell lung cancer. Cancer Research. 72(8_Supplement). 2663–2663. 3 indexed citations
19.
Mirshahidi, Hamid, et al.. (2010). Updates in non-small cell lung cancer - insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. Journal of Hematology & Oncology. 3(1). 18–18. 11 indexed citations
20.
Mirshahidi, Hamid & Jame Abraham. (2004). Managing early breast cancer. Postgraduate Medicine. 116(4). 23–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane‐Chloé Trone Breakdown of academic impact, for papers by Troels Bechmann Breakdown of academic impact, for papers by Irving Taylor Breakdown of academic impact, for papers by Dae Sik Yang Breakdown of academic impact, for papers by Christina H. Son Breakdown of academic impact, for papers by L Buffoni Breakdown of academic impact, for papers by Tabassum Wadasadawala Breakdown of academic impact, for papers by N.S. Russell Breakdown of academic impact, for papers by Afsheen N. Iqbal Breakdown of academic impact, for papers by Roman Makarewicz
Rankless by CCL
2026